The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology
Frontiers in Pharmacology · 17.05.2023 · 14
DOI: 10.3389/fphar.2023.1192210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.05.2023. Verfasst von Kang Rong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Helicobacter Pylori and Microbiota and Gastrointestinal Cancer, Marshall B. J. Medical Research Center of Zhengzhou Universit…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Colorectal cancer (CRC) is a common cancer that cannot be detected at an early stage and is a major challenge in oncology research. Studies have shown that vitamin D3 has some anti-cancer and preventive effects on colorectal cancer, but the exact anti-cancer mechanism is not clear. We applied the relevant research methods of network pharmacology to speculate and validate the possible potential pharmacological mechanisms of vitamin D3 for the prevention of colorectal cancer, and to provide more theoretical support for the clinical anticancer effects of vitamin D3.
Methods
The relevant targets for vitamin D3 and CRC were obtained from the database of drug and disease targets, respectively. The target of vitamin D3 and the target of colorectal cancer were taken to intersect to obtain common targets. Then, the PPI network was constructed. In addition, the pathways of drug-disease interactions were predicted by GO and KEGG enrichment analysis. Finally, the obtained results were verified to ensure the reliability of the experiments.
Results
51 targets of vitamin D3 for the prevention of colorectal cancer were obtained. The 10 core targets were obtained from the PPI network. The 10 core targets include: ALB, SRC, MMP9, PPARG, HSP90AA1, IGF1, EGFR, MAPK1, MAP2K1 and IGF1R. The core targets were further validated by molecular docking and animal experiments. The results suggest that vitamin D3 plays a key role in the prevention of CRC through core targets, PI3K-Akt pathway, HIF-1 pathway, and FoxO pathway.
Conclusion
This study will provide more theoretical support for vitamin D3 to reduce the incidence of CRC and is important to explore more pharmacological effects of vitamin D3.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Key Laboratory of Helicobacter Pylori and Microbiota and Gastrointestinal Cancer, Marshall B. J. Medical Research Center of Zhengzhou University, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, C…
- Department of Gastroenterology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- The First Clinical Medical School of Henan University of Chinese Medicine, Zhengzhou, China.
Zitieren
APA
Rong, K., He, Q., Chen, S., Yu, Y., Mei, L., Mi, Y., Mu, L., Zhu, M., Nan, M., Zhang, X., Wan, Z., Huang, H., & Zheng, P. (2023). The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1192210
Vancouver
Rong K, He Q, Chen S, Yu Y, Mei L, Mi Y, et al. The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1192210
BibTeX
@article{Rong2023,
author = {Rong, Kang and He, Qingmin and Chen, Shu and Yu, Yong and Mei, Lu and Mi, Yang and Mu, Liufan and Zhu, Mingyang and Nan, Mengjiao and Zhang, Xiaoyang and Wan, Zhaoyang and Huang, Huang and Zheng, Pengyuan},
title = {The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1192210}
}
EUVIMED